PetMed Express (PETS) News Today

Federated Hermes Inc. lifted its position in shares of PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 54.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 606,430 shares of the company's stock after purc

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,660,000 shares, a decline of 23.5% from the July 15th total of 2,170,000 shares. Approximately 8.2% of the shares of the stock are sold short. Based on an average trading volume of 399,200 shares, the short-interest ratio is presently 4.2 days.

PetMed Express (NASDAQ:PETS - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.18 EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.30. The business had revenue of $67.95 million for the quarter, compared to analysts' expectations of $77.52 million. PetMed Express had a negative net margin of 2.85% and a negative return on equity of 7.09%.

Lake Street Capital reiterated a "hold" rating and set a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a report on Wednesday.

PetMed Express (NASDAQ:PETS) will be releasing earnings after the market closes on Tuesday, August 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=611491)

Connors Investor Services Inc. trimmed its position in PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 85.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,503 shares of the company's stock aft

Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 2,025.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 700,916 sha

Lake Street Capital decreased their target price on PetMed Express from $9.00 to $7.00 and set a "buy" rating on the stock in a research report on Wednesday.

Invenomic Capital Management LP purchased a new stake in shares of PetMed Express, Inc. (NASDAQ:PETS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 215,800 shares of the company's stock, valued at approximately $1,63